Patient Engagement Platforms Market is Projected to Reach Nearly US$ 93.4 Bn by 2032 | FMI

  The Global Patient Engagement Platforms Market is anticipated to grow at a 17% CAGR during the forecast period, reaching nearly US$ 93.4 Billion by 2032, up from US$ 16.6 Billion in 2021.

Factors driving the patient engagement platforms market share include favourable government laws and activities to promote the adoption of HCIT solutions, the benefits of patient rounding solutions, and the growing number of stakeholder alliances and partnerships.

Get Full Access @ https://www.futuremarketinsights.com/reports/patient-engagement-platforms-market

However, constraints such as costly IT infrastructure investments and a dearth of trained IT workers in the healthcare industry are projected to limit the demand for patient engagement platforms to some extent over the forecast period.

Government policies and activities that encourage the adoption of HCIT solutions are driving the sales of patient engagement platforms forward.

The rising demand for high-quality treatment has driven healthcare systems around the world to implement cutting-edge technology that assists cut costs, improving care quality, and eliminating administrative inefficiencies. This guarantees that all hospitals have access to better patient experience platforms.

The HITECH Act formed ONC and gave the US Department of Health and Human Services the authority to create initiatives to promote health IT and improve healthcare quality, safety, and efficiency. The usage of patient experience technology solutions is likely to increase as a result of such activities.

The majority of healthcare organizations engaged in patient engagement in healthcare lack the necessary infrastructure (technology, data, and other resources) to implement complex HCIT solutions.

Providers must make additional expenditures in infrastructure development to support IT systems in order to properly integrate patient experience technology solutions.

Owing to the efficiency of a patient experience technology solution is determined by the hardware and software available to the end-user, any end-user interested in implementing one must first invest extensively in these areas. Many hospitals have limited funds; such large investments are difficult for them to make.

Patient engagement platforms market adoption is on the rise as a result of factors such as the rising prevalence of chronic diseases and the growing geriatric population.

According to the American Diabetes Association 2020, 1.5 million new cases of diabetes are diagnosed in the United States each year. Companies are focused on the development of patient engagement solutions in response to the rising number of diabetic patients.

Data security issues are extremely critical in the digital patient engagement platforms since the infrastructure can be exposed to networks that are not part of the organization's secure network.

Key Takeaways

  • In 2026, the market for patient experience technology in the United States is predicted to be worth $299 million.
  • With a revenue share of over 75.0 per cent in 2021, the web and cloud-based category dominated the market. These solutions are becoming more popular as a result of remote access to real-time data tracking, integrated features, easy accessibility, low handling costs, and simple data backup.
  • In 2020, the technology category impacted the majority of the patient experience technology and patient engagement platforms market outlook in the United States. Technology is an essential aspect of the patient experience journey, and it is expected to increase at the fastest CAGR during the projection period.
  • In 2021, the software and hardware sector had the greatest patient engagement platforms market share of more than 60.0 per cent, and it is predicted to grow at the quickest CAGR over the forecast period.
  • As the key component of every patient engagement solution, communication accounted for the greatest patient engagement platforms market share of approximately 35.0 per cent in 2021. A spike in demand and implementation of telehealth, mhealth, and other virtual communication options via audio, video, and text is responsible for this huge proportion.
  • Due to the presence of significant players, increased acceptance of mhealth and EHR, and expanding investment in patient engagement software by big enterprises, North America held the largest revenue share of about 35.0 per cent in 2021.

"During the forecasted period, the Asia Pacific patient engagement platforms market is predicted to grow at an attractive rate of 18.8%. The growth of this region is aided by the economic prosperity of countries such as India and China."

Competitive Landscape

Due to the presence of large and small enterprises, the demand for patient engagement platforms has been characterized by severe rivalry. A considerable portion of the market is controlled by key players. To increase their market presence, major firms are pursuing new strategies such as geographic penetration, new product/solution development, mergers and acquisitions, partnerships, and strategic alliances.

Some prominent patient engagement platform vendors in the global patient engagement platforms market include NextGen Healthcare, Inc., CPSI, McKesson Corporation, Allscripts Healthcare, LLC, Experian Information Solutions, Inc., ResMed, Epic Systems Corporation, Klara Technologies, Inc., Koninklijke Philips N.V., and Cerner Corporation.

  • Press Ganey (US) collaborated with The Beryl Institute (US) in 2021, a global network of healthcare professionals and seasoned champions. Press Ganey will focus on expanding the healthcare experience movement as a result of this partnership.
  • Vocera (US) and Amazon (US) cooperated in 2021 to create the Vocera Skill tool for Alexa. Vocera Skill will add hands-free and immersive voice experiences for patients and their families to Vocera's ecosystem.
  • SONIFI Health (US) and CipherHealth (US) formed a strategic agreement in 2021 to combine their primary strengths and give health systems a more comprehensive approach to patient communication and successful care planning.

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more

Clostridium Diagnostics Market in US is anticipated to secure a market value worth US$ 2.7 Billion by 2032 | FMI

Image
  The global Clostridium Diagnostics Market is expected to grow at a CAGR of 12.2% during the forecast period, from US$ 2.5 billion in 2022 to US$ 7.8 billion by 2032. The market grew at a CAGR of 13.6% between 2015 and 2021. The rising prevalence of clostridium-related diseases, as well as increased campaigns to educate people about the condition, are driving the market growth. To learn more about this report @ https://www.futuremarketinsights.com/reports/clostridium-diagnostics-market here has been an increased focus of players in the market to offer vaccines, which can augment the market size in the forecast period. For instance, in March 2022, Japan launched a new center, with a budget of US$ 1.6 Billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases. SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects. Awareness camp...
Read more